305 related articles for article (PubMed ID: 16797052)
1. A gamma-herpesvirus deficient in replication establishes chronic infection in vivo and is impervious to restriction by adaptive immune cells.
Tibbetts SA; Suarez F; Steed AL; Simmons JA; Virgin HW
Virology; 2006 Sep; 353(1):210-9. PubMed ID: 16797052
[TBL] [Abstract][Full Text] [Related]
2. Natural history of murine gamma-herpesvirus infection.
Nash AA; Dutia BM; Stewart JP; Davison AJ
Philos Trans R Soc Lond B Biol Sci; 2001 Apr; 356(1408):569-79. PubMed ID: 11313012
[TBL] [Abstract][Full Text] [Related]
3. CD4 T cell control of acute and latent murine gammaherpesvirus infection requires IFNgamma.
Sparks-Thissen RL; Braaten DC; Hildner K; Murphy TL; Murphy KM; Virgin HW
Virology; 2005 Aug; 338(2):201-8. PubMed ID: 15961135
[TBL] [Abstract][Full Text] [Related]
4. Ex vivo stimulation of B cells latently infected with gammaherpesvirus 68 triggers reactivation from latency.
Moser JM; Upton JW; Gray KS; Speck SH
J Virol; 2005 Apr; 79(8):5227-31. PubMed ID: 15795307
[TBL] [Abstract][Full Text] [Related]
5. Gamma interferon blocks gammaherpesvirus reactivation from latency in a cell type-specific manner.
Steed A; Buch T; Waisman A; Virgin HW
J Virol; 2007 Jun; 81(11):6134-40. PubMed ID: 17360749
[TBL] [Abstract][Full Text] [Related]
6. A replication-deficient murine gamma-herpesvirus blocked in late viral gene expression can establish latency and elicit protective cellular immunity.
Kayhan B; Yager EJ; Lanzer K; Cookenham T; Jia Q; Wu TT; Woodland DL; Sun R; Blackman MA
J Immunol; 2007 Dec; 179(12):8392-402. PubMed ID: 18056385
[TBL] [Abstract][Full Text] [Related]
7. Vaccination with inactivated murine gammaherpesvirus 68 strongly limits viral replication and latency and protects type I IFN receptor knockout mice from a lethal infection.
Aricò E; Robertson KA; Belardelli F; Ferrantini M; Nash AA
Vaccine; 2004 Mar; 22(11-12):1433-40. PubMed ID: 15063566
[TBL] [Abstract][Full Text] [Related]
8. Type I interferons and IRF-1 play a critical role in the control of a gammaherpesvirus infection.
Dutia BM; Allen DJ; Dyson H; Nash AA
Virology; 1999 Sep; 261(2):173-9. PubMed ID: 10497103
[TBL] [Abstract][Full Text] [Related]
9. Establishment and maintenance of long-term murine gammaherpesvirus 68 latency in B cells in the absence of CD40.
Willer DO; Speck SH
J Virol; 2005 Mar; 79(5):2891-9. PubMed ID: 15709008
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of a murine gammaherpesvirus infection immunocompromised mice.
Kulkarni AB; Holmes KL; Fredrickson TN; Hartley JW; Morse HC
In Vivo; 1997; 11(4):281-91. PubMed ID: 9292294
[TBL] [Abstract][Full Text] [Related]
11. Role of B-cell proliferation in the establishment of gammaherpesvirus latency.
Moser JM; Upton JW; Allen RD; Wilson CB; Speck SH
J Virol; 2005 Aug; 79(15):9480-91. PubMed ID: 16014911
[TBL] [Abstract][Full Text] [Related]
12. Early establishment of gamma-herpesvirus latency: implications for immune control.
Flaño E; Jia Q; Moore J; Woodland DL; Sun R; Blackman MA
J Immunol; 2005 Apr; 174(8):4972-8. PubMed ID: 15814726
[TBL] [Abstract][Full Text] [Related]
13. Recombinant murine gammaherpesvirus 68 (MHV-68) as challenge virus to test efficacy of vaccination against chronic virus infections in the mouse model.
El-Gogo S; Staib C; Meyr M; Erfle V; Sutter G; Adler H
Vaccine; 2007 May; 25(20):3934-45. PubMed ID: 17433507
[TBL] [Abstract][Full Text] [Related]
14. Alpha/beta interferons regulate murine gammaherpesvirus latent gene expression and reactivation from latency.
Barton ES; Lutzke ML; Rochford R; Virgin HW
J Virol; 2005 Nov; 79(22):14149-60. PubMed ID: 16254350
[TBL] [Abstract][Full Text] [Related]
15. Unraveling immunity to gamma-herpesviruses: a new model for understanding the role of immunity in chronic virus infection.
Virgin HW; Speck SH
Curr Opin Immunol; 1999 Aug; 11(4):371-9. PubMed ID: 10448140
[TBL] [Abstract][Full Text] [Related]
16. Gamma interferon blocks gammaherpesvirus reactivation from latency.
Steed AL; Barton ES; Tibbetts SA; Popkin DL; Lutzke ML; Rochford R; Virgin HW
J Virol; 2006 Jan; 80(1):192-200. PubMed ID: 16352543
[TBL] [Abstract][Full Text] [Related]
17. Lytic cycle T cell epitopes are expressed in two distinct phases during MHV-68 infection.
Liu L; Flaño E; Usherwood EJ; Surman S; Blackman MA; Woodland DL
J Immunol; 1999 Jul; 163(2):868-74. PubMed ID: 10395681
[TBL] [Abstract][Full Text] [Related]
18. MHV-68 producing mIFNα1 is severely attenuated in vivo and effectively protects mice against challenge with wt MHV-68.
Aricò E; Monque DM; D'Agostino G; Moschella F; Venditti M; Kalinke U; Allen DJ; Stewart JP; Nash AA; Belardelli F; Ferrantini M
Vaccine; 2011 May; 29(23):3935-44. PubMed ID: 21481326
[TBL] [Abstract][Full Text] [Related]
19. Antibody to a lytic cycle viral protein decreases gammaherpesvirus latency in B-cell-deficient mice.
Gangappa S; Kapadia SB; Speck SH; Virgin HW
J Virol; 2002 Nov; 76(22):11460-8. PubMed ID: 12388707
[TBL] [Abstract][Full Text] [Related]
20. The murine gammaherpesvirus 68 v-cyclin is a critical regulator of reactivation from latency.
van Dyk LF; Virgin HW; Speck SH
J Virol; 2000 Aug; 74(16):7451-61. PubMed ID: 10906198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
